| - GRCh37:
- Chr9:100190748-103062956
| ALG2, ANKS6, ANP32B, COL15A1, CORO2A, ERP44, FOXE1, GABBR2, GALNT12, HEMGN, INVS, NANS, NCBP1, NR4A3, SEC61B, STX17, TBC1D2, TDRD7, TGFBR1, TMOD1, TRIM14, TRMO, TSTD2, XPA | | Familial thoracic aortic aneurysm and aortic dissection, ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14
| Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984096
- GRCh38:
- Chr9:99221814
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Aug 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983809
- GRCh38:
- Chr9:99221527
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980549
- GRCh38:
- Chr9:99218267
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984030
- GRCh38:
- Chr9:99221748
| ALG2 | I49M | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981116
- GRCh38:
- Chr9:99218834
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984081
- GRCh38:
- Chr9:99221799
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984135
- GRCh38:
- Chr9:99221853
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983853
- GRCh38:
- Chr9:99221571
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983894
- GRCh38:
- Chr9:99221612
| ALG2 | V95I | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984042
- GRCh38:
- Chr9:99221760
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Dec 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980626
- GRCh38:
- Chr9:99218344
| ALG2 | Y281H | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980738
- GRCh38:
- Chr9:99218456
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980917
- GRCh38:
- Chr9:99218635
| ALG2 | F184L | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980503
- GRCh38:
- Chr9:99218221
| ALG2 | P322T | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984174
- GRCh38:
- Chr9:99221892
| ALG2 | M1I | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984120
- GRCh38:
- Chr9:99221838
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983913
- GRCh38:
- Chr9:99221631
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980334
- GRCh38:
- Chr9:99218052
| ALG2 | R378H | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980287
- GRCh38:
- Chr9:99218005
| ALG2 | V394L | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983942
- GRCh38:
- Chr9:99221660
| ALG2 | L79V | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984033
- GRCh38:
- Chr9:99221751
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980716-101980717
- GRCh38:
- Chr9:99218434-99218435
| ALG2 | R251C | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980721
- GRCh38:
- Chr9:99218439
| ALG2 | Q249R | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980405
- GRCh38:
- Chr9:99218123
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Mar 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980801
- GRCh38:
- Chr9:99218519
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Oct 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983895
- GRCh38:
- Chr9:99221613
| ALG2 | M94I | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Feb 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983849
- GRCh38:
- Chr9:99221567
| ALG2 | D110H | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981015
- GRCh38:
- Chr9:99218733
| ALG2 | L151P | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983861
- GRCh38:
- Chr9:99221579
| ALG2 | D106N | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980326-101980327
- GRCh38:
- Chr9:99218044-99218045
| ALG2 | S381T | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981085
- GRCh38:
- Chr9:99218803
| ALG2 | R128G | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980807
- GRCh38:
- Chr9:99218525
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980357
- GRCh38:
- Chr9:99218075
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981077-101981079
- GRCh38:
- Chr9:99218795-99218797
| ALG2 | R130del | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984069
- GRCh38:
- Chr9:99221787
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980538
- GRCh38:
- Chr9:99218256
| ALG2 | S310Y | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983850
- GRCh38:
- Chr9:99221568
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984172
- GRCh38:
- Chr9:99221890
| ALG2 | A2V | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983869
- GRCh38:
- Chr9:99221587
| ALG2 | F103fs | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980496
- GRCh38:
- Chr9:99218214
| ALG2 | N324S | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980493
- GRCh38:
- Chr9:99218211
| ALG2 | E325G | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980653
- GRCh38:
- Chr9:99218371
| ALG2 | E272K | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980518
- GRCh38:
- Chr9:99218236
| ALG2 | C317R | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983871
- GRCh38:
- Chr9:99221589
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984080
- GRCh38:
- Chr9:99221798
| ALG2 | V33L | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984045
- GRCh38:
- Chr9:99221763
| ALG2 | C45fs | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984059
- GRCh38:
- Chr9:99221777
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980594
- GRCh38:
- Chr9:99218312
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981108
- GRCh38:
- Chr9:99218826
| ALG2 | C120Y | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983840
- GRCh38:
- Chr9:99221558
| ALG2 | V113M | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980545-101980546
- GRCh38:
- Chr9:99218263-99218264
| ALG2 | K308fs | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980462
- GRCh38:
- Chr9:99218180
| ALG2 | M335I | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jan 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980232
- GRCh38:
- Chr9:99217950
| ALG2 | T412N | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980776
- GRCh38:
- Chr9:99218494
| ALG2 | I231V | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jan 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983925-101983926
- GRCh38:
- Chr9:99221643-99221644
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980792
- GRCh38:
- Chr9:99218510
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983998
- GRCh38:
- Chr9:99221716
| ALG2 | F60Y | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980907
- GRCh38:
- Chr9:99218625
| ALG2 | T187I | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984030
- GRCh38:
- Chr9:99221748
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984143
- GRCh38:
- Chr9:99221861
| ALG2 | V12L | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983885
- GRCh38:
- Chr9:99221603
| ALG2 | A98T | ALG2-congenital disorder of glycosylation | Uncertain significance (May 21, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980453
- GRCh38:
- Chr9:99218171
| ALG2 | Q338H | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980877
- GRCh38:
- Chr9:99218595
| ALG2 | D197G | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983994
- GRCh38:
- Chr9:99221712
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980276
- GRCh38:
- Chr9:99217994
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Mar 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984144
- GRCh38:
- Chr9:99221862
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983821
- GRCh38:
- Chr9:99221539
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981041
- GRCh38:
- Chr9:99218759
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983964
- GRCh38:
- Chr9:99221682
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980810
- GRCh38:
- Chr9:99218528
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983979
- GRCh38:
- Chr9:99221697
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983809
- GRCh38:
- Chr9:99221527
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984108
- GRCh38:
- Chr9:99221826
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984171
- GRCh38:
- Chr9:99221889
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Nov 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984107
- GRCh38:
- Chr9:99221825
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Aug 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983815
- GRCh38:
- Chr9:99221533
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981092
- GRCh38:
- Chr9:99218810
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980896
- GRCh38:
- Chr9:99218614
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (May 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981065
- GRCh38:
- Chr9:99218783
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980442
- GRCh38:
- Chr9:99218160
| ALG2 | I342T | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983960
- GRCh38:
- Chr9:99221678
| ALG2 | D73H | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983913
- GRCh38:
- Chr9:99221631
| ALG2 | | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983830
- GRCh38:
- Chr9:99221548
| ALG2 | Q116R | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980848
- GRCh38:
- Chr9:99218566
| ALG2 | S207G | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Nov 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984101
- GRCh38:
- Chr9:99221819
| ALG2 | V26M | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980960
- GRCh38:
- Chr9:99218678
| ALG2 | M169I | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980734
- GRCh38:
- Chr9:99218452
| ALG2 | E245K | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jun 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980672
- GRCh38:
- Chr9:99218390
| ALG2 | I265M | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983992
- GRCh38:
- Chr9:99221710
| ALG2 | E62G | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101983997
- GRCh38:
- Chr9:99221715
| ALG2 | F60L | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980703
- GRCh38:
- Chr9:99218421
| ALG2 | T255I | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Aug 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980895
- GRCh38:
- Chr9:99218613
| ALG2 | L191P | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984009
- GRCh38:
- Chr9:99221727
| ALG2 | | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980868
- GRCh38:
- Chr9:99218586
| ALG2 | Y200S | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome 14 | Uncertain significance (Sep 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980430
- GRCh38:
- Chr9:99218148
| ALG2 | S346L | Inborn genetic diseases, Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation
| Uncertain significance (Jan 6, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:101980239
- GRCh38:
- Chr9:99217957
| ALG2 | Y410H | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101980978
- GRCh38:
- Chr9:99218696
| ALG2 | E163D | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101981024-101981025
- GRCh38:
- Chr9:99218742-99218743
| ALG2 | D148fs | Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:101984161
- GRCh38:
- Chr9:99221879
| ALG2 | G6R | Inborn genetic diseases, Congenital myasthenic syndrome 14, ALG2-congenital disorder of glycosylation
| Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |